Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds OTR Global Upgrades Restaurant Brands Intl to Positive

OTR Global Upgrades Restaurant Brands Intl to Positive

OTR Global upgrades Restaurant Brands Intl (NYSE:QSR) from Mixed to Positive.

byBenzinga Newsdesk

October 10, 2022

1 minute read

OTR Global upgrades Restaurant Brands Intl (NYSE:QSR) from Mixed to Positive.

Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits

By Nabaparna Bhattacharya

October 21, 9:56 PM

As obesity rates climb worldwide, so does the demand

LLY

Crypto Analyst Predicts Ethereum’s Sky-high Rise And Bitcoin’s Million-dollar Future: ‘The Time Is Now!’

By Bibhu Pattnaik

November 11, 11:44 AM

Arthur Hayes, crypto expert and co-founder of BitMEX, has doubled his bullish stance for Bitcoin (CRYPTO: BTC) and fores

BTC

News
Tech

Big Tech In Trouble: Apple To Receive Hefty Fine For Alleged EU Law Breach

By Benzinga Neuro

February 18, 11:14 AM

In a first, tech giant Apple Inc. (NASDAQ: AAPL) is set to be fined by Brussels over accusations of violating EU law related to its music streaming

AAPL

Inventiva Announces That Its Partner Sino Biopharm Received IND Approval From The NMPA To Initiate Clinical Trial With Lanifibranor In China

By Happy Mohamed

May 25, 4:01 PM

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm's subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASH Sino Biopharm will

IVA

OTR Global Upgrades Restaurant Brands Intl to Positive

Related Posts

Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits

Crypto Analyst Predicts Ethereum’s Sky-high Rise And Bitcoin’s Million-dollar Future: ‘The Time Is Now!’

Big Tech In Trouble: Apple To Receive Hefty Fine For Alleged EU Law Breach

Inventiva Announces That Its Partner Sino Biopharm Received IND Approval From The NMPA To Initiate Clinical Trial With Lanifibranor In China